Welcome to the Forefront of Oncology Therapeutics and Cancer Drug Development
Welcome to the Forefront of Oncology Therapeutics and Cancer Drug Development
The Journal of Oncology Therapeutics and Drug Development is a multidisciplinary, peer-reviewed platform dedicated to advancing research in cancer treatment innovation and pharmaceutical development. The journal focuses on the discovery, optimization, and clinical evaluation of novel anticancer agents including small molecules, biologics, targeted therapies, immunotherapies, and combination strategies. Its scope encompasses the full spectrum of oncology drug development, from preclinical mechanistic studies and translational research to clinical trial outcomes, biomarker discovery, and therapeutic optimization. The journal also highlights emerging technologies such as nanomedicine, precision oncology, AI-driven drug design, and advanced delivery systems aimed at improving therapeutic index and patient outcomes.
🌐Aims and Scope
The Journal of Oncology Therapeutics and Drug Development is a
peer-reviewed, open-access journal committed to advancing scientific research
and innovation in the development of anticancer therapies. The journal serves
as an international platform for the publication of high-quality research,
breakthrough discoveries, and emerging therapeutic approaches that contribute
to improved cancer treatment, drug discovery, and clinical outcomes.
The journal
covers a comprehensive range of topics related to oncology therapeutics and
drug development, including but not limited to:
- Oncology
Drug Discovery and Design
- Targeted
Cancer Therapies
- Immuno-Oncology
and Immune-Based Treatments
- Pharmaceutical
Sciences and Anticancer Agents
- Nanotechnology
and Advanced Drug-Delivery Systems
- Preclinical
and Translational Oncology Research
- Clinical
Trials and Therapeutic Evaluation
- Cancer
Biomarkers and Precision Medicine
- Molecular
Oncology and Mechanism-Based Drug Development
- Radiopharmaceuticals
and Novel Therapeutic Modalities
- Toxicology, Pharmacokinetics, and Pharmacodynamics
The journal
publishes original research articles, reviews, short communications, case
studies, clinical trial reports, and expert perspectives that meaningfully
advance the understanding and development of innovative cancer therapeutics.
📚 Journal Highlights & Key Areas:
Our journal covers a broad spectrum of modern oncology research, with a strong focus on innovative therapeutic approaches and advancements in cancer drug development. Key highlights of our published research include:
- Expanding Global Access to Cancer Therapies
- Biomarkers in Action
- Pediatric Chemo Advances
- AI-Driven Drug Discovery
- Advanced Drug Delivery Technologies
- Personalized Cancer Dosing
- Breakthrough Targeted Therapies
- Overcoming Drug Resistance
- Targeted Protein Degradation PROTACs
🔍PEER REVIEW PROCESS:
🌍Our Reach and Credibility
The impact and credibility of the Journal of Cancer Chemotherapy are demonstrated by our indexing in major international databases and directories. This ensures maximum visibility and discoverability for your published work.
We are indexed in:
Google Scholar
DOAJ
CrossRef
PubMed
MEDLINE
ResearchBib
OAJI
Sindexs
EBSCO A-Z / Host - WorldCat
A Rigorous and Trusted Publication Process
We are committed to upholding the highest standards of academic integrity through a meticulous peer-review process.
Why Publish With Us?
Rapid Peer Review: Efficient and constructive feedback from experts in the field.
Open Access: Immediate and unrestricted online access to your work.
Global Reach: Your research reaches a worldwide audience of clinicians, researchers, and policymakers.
Expert Editorial Board: Guided by leading international scholars.
☎ CONTACT US
We welcome inquiries from authors, reviewers, readers, and institutions.
For General Queries and Manuscript Support
Email: cancerjournal@globalmeetx.net
Phone: +44 7897 072181
For Technical Support with the Submission System
Email: support@globalmeetx.com
We strive to respond to all messages promptly.